DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 018299
Email this page to a colleague
» See Plans and Pricing
NDA 018299 describes VIROPTIC, which is a drug marketed by Monarch Pharms and is included in one NDA. Additional details are available on the VIROPTIC profile page.
The generic ingredient in VIROPTIC is trifluridine. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the trifluridine profile page.
The generic ingredient in VIROPTIC is trifluridine. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the trifluridine profile page.
Summary for 018299
| Tradename: | VIROPTIC |
| Applicant: | Monarch Pharms |
| Ingredient: | trifluridine |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 018299
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AT | RLD: | Yes | ||||
Complete Access Available with Subscription
